文献速递真菌感染

念珠菌血症持续时间与临床及医疗资源利用结局的关联

Association Between Duration of Candidemia and Clinical and Healthcare Resource Utilization Outcomes Among Hospitalized Adult Patients With Candidemia Who Received Empiric Treatment With an Echinocandin Across United States Hospitals.
PubMed 文献 · Clin Infect Dis · 2026-01-01

该回顾性多中心研究纳入美国867例住院成年念珠菌血症患者,均接受经验性棘白菌素治疗。多变量分析显示,念珠菌血症每延长1天,院内死亡调整比值增加3%,指数采血日后的调整中位住院时间增加1.0天,调整中位总费用增加3006美元。

要点

  • 念珠菌血症持续时间超过1天者死亡、住院时间与费用均高于仅1天者。
  • 每额外1天念珠菌血症,院内死亡调整比值增加3%。
  • 每额外1天念珠菌血症,指数采血日后调整中位住院时间增加1.0天。

核心结论

  • 念珠菌血症持续时间延长与更差的患者结局及更高的医疗费用相关。
  • 鉴于本研究为探索性观察性研究,需进一步大规模研究确认这些发现。

研究设计与样本

  • 回顾性、多中心研究,使用PINCI AI Healthcare Database(2016年1月至2019年4月)。
  • 纳入住院成人(≥18岁)临床血培养鉴定为念珠菌属、在索引血培养±2天内接受经验性棘白菌素治疗≥3天者。
  • 共867例患者符合标准。

主要发现

  • 念珠菌血症持续超过1天的患者较仅1天者院内死亡率显著更高、住院时间更长、住院费用更高。
  • 每额外1天念珠菌血症,院内死亡调整比值增加3%。
  • 每额外1天念珠菌血症,指数采血日后调整中位住院时间增加1.0天。
  • 每额外1天念珠菌血症,指数采血日后调整中位总费用增加3006美元。

临床怎么用

  • 对接受经验性棘白菌素治疗的住院念珠菌血症成人,应关注血培养清除时间。
  • 念珠菌血症持续时间延长提示预后更差与资源消耗更高,可作为临床风险分层参考。

局限性

  • 本研究为探索性、观察性研究,需进一步大规模研究确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Time to bloodstream clearance is a critical prognostic indicator in various infections, yet limited data exist on the relationship between time to mycological clearance and outcomes in candidemia. This study aimed to assess the association between the duration of candidemia and outcomes in adult, hospitalized patients receiving empiric echinocandin treatment across US hospitals. METHODS: A retrospective, multicenter study using the PINCI AI Healthcare Database (1/2016-4/2019) was conducted. Inclusion criteria: hospitalized adults (≥18 years) with Candida spp. identified on a clinical blood culture who received empiric echinocandin therapy (±2 days of index Candida spp. blood culture) for ≥3 days. Outcomes assessed were in-hospital mortality, length of stay, and hospital costs. The associations between increasing duration of candidemia relative to a single day of candidemia and outcomes were examined. RESULTS: A total of 867 patients met the criteria. Multivariable analysis showed that patients with candidemia lasting more than 1 day had significantly higher mortality, longer length of stay, and higher hospital costs compared to those with only 1 day of candidemia. For each additional day of candidemia, the adjusted odds of in-hospital mortality increased by 3%, the adjusted median hospital length of stay after index collection day increased by 1.0 days, and the adjusted median total costs after index collection day increased by $3006. CONCLUSIONS: Prolonged candidemia is associated with worse patient outcomes and higher healthcare costs. Further large-scale studies are needed to confirm these findings given the exploratory and observational nature of this study.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Lodise TP, Garey KW, Aram JA, et al. Association Between Duration of Candidemia and Clinical and Healthcare Resource Utilization Outcomes Among Hospitalized Adult Patients With Candidemia Who Received Empiric Treatment With an Echinocandin Across United States Hospitals. Clin Infect Dis. 2026. PMID: 40889279. doi:10.1093/cid/ciaf472

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。